Negative sentiment towards PHAT reflected by a jump of 0.46% in short interest

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Phathom Pharmaceuticals Inc shares valued at $153,513 were sold by Curran Terrie on Mar 22 ’24. At $9.11 per share, Curran Terrie sold 16,851 shares. The insider’s holdings dropped to 410,784 shares worth approximately […]

The Attractiveness of Investing In Phathom Pharmaceuticals Inc (PHAT) is Growing

Phathom Pharmaceuticals Inc’s recent filing unveils that its 10% Owner TAKEDA PHARMACEUTICAL CO LTD unloaded Company’s shares for reported $30.0 million on Jan 24 ’24. In the deal valued at $8.10 per share,3,703,703 shares were sold. As a result of this transaction, TAKEDA PHARMACEUTICAL CO LTD now holds 3,755,583 shares worth roughly $41.39 million. Then, […]

Keeping an Eye on Phathom Pharmaceuticals Inc (PHAT) After Insider Trading Activity

Phathom Pharmaceuticals Inc’s recent filing unveils that its 10% Owner TAKEDA PHARMACEUTICAL CO LTD unloaded Company’s shares for reported $30.0 million on Jan 24 ’24. In the deal valued at $8.10 per share,3,703,703 shares were sold. As a result of this transaction, TAKEDA PHARMACEUTICAL CO LTD now holds 3,755,583 shares worth roughly $31.1 million. Then, […]

PHAT’s short interest reaches 8.67 million shares on Feb 29, 2024

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Phathom Pharmaceuticals Inc shares valued at $29,999,994 were sold by TAKEDA PHARMACEUTICAL CO LTD on Jan 24 ’24. At $8.10 per share, TAKEDA PHARMACEUTICAL CO LTD sold 3,703,703 shares. The insider’s […]

Phathom Pharmaceuticals Inc [PHAT] Insider Activity: An Update for Investors

Phathom Pharmaceuticals Inc’s filing revealed that its 10% Owner TAKEDA PHARMACEUTICAL CO LTD unloaded Company’s shares for reported $30.0 million on Jan 24 ’24. In the deal valued at $8.10 per share,3,703,703 shares were sold. As a result of this transaction, TAKEDA PHARMACEUTICAL CO LTD now holds 3,755,583 shares worth roughly $31.02 million. Then, Henderson […]

Phathom Pharmaceuticals Inc [NASDAQ: PHAT] Sees Decrease in Stock Value

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Phathom Pharmaceuticals Inc shares valued at $29,999,994 were sold by TAKEDA PHARMACEUTICAL CO LTD on Jan 24 ’24. At $8.10 per share, TAKEDA PHARMACEUTICAL CO LTD sold 3,703,703 shares. The insider’s holdings dropped to 3,755,583 shares worth […]

Keeping an Eye on Phathom Pharmaceuticals Inc (PHAT) After Insider Trading Activity

Phathom Pharmaceuticals Inc’s filing revealed that its 10% Owner TAKEDA PHARMACEUTICAL CO LTD unloaded Company’s shares for reported $30.0 million on Jan 24. In the deal valued at $8.10 per share,3,703,703 shares were sold. As a result of this transaction, TAKEDA PHARMACEUTICAL CO LTD now holds 3,755,583 shares worth roughly $38.64 million. Then, Henderson Molly […]

Sharp increase in PHAT’s short interest leads to surge in days-to-cover ratio

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Phathom Pharmaceuticals Inc shares valued at $29,999,994 were sold by TAKEDA PHARMACEUTICAL CO LTD on Jan 24. At $8.10 per share, TAKEDA PHARMACEUTICAL CO LTD sold 3,703,703 shares. The insider’s holdings dropped to 3,755,583 shares worth approximately […]

PHAT’s short interest shows a sharp rise on Jan 31, 2024

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Phathom Pharmaceuticals Inc shares valued at $29,999,994 were sold by TAKEDA PHARMACEUTICAL CO LTD on Jan 24. At $8.10 per share, TAKEDA PHARMACEUTICAL CO LTD sold 3,703,703 shares. The insider’s holdings dropped to 3,755,583 […]